Results 241 to 250 of about 375,473 (301)
Contesting Cannabis Legalization in Nigeria: Hidden Narratives of Illicit Farmers and Traders
This article examines narratives of cannabis legalization in Nigeria. While most existing research on cannabis legalization has concentrated on the global North, we focus on one of Africa's largest cannabis markets, as well as the views of actors heavily criminalized and excluded from policy debates.
Ediomo‐Ubong Nelson+1 more
wiley +1 more source
A drug education manual concerning illicit drugs and psychotropics - For teachers in secondary schools in the Member States of the European Community. Medicine. EUR 10594 EN [PDF]
Basso, F.+3 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Pharmacology & Therapeutics, 1968
Naloxone is a potent and rapidly acting narcotic antagonist, with a duration of action which is shorter (3 to 4 hours) than that of heroin. In a clinical trial of naloxone in the treatment of heroin dependence, a daily oral dose of 100 mg. at 8 A.M. and 7 P.M. effectively blockaded 20 mg.
Arnoldo Mora+6 more
openaire +3 more sources
Naloxone is a potent and rapidly acting narcotic antagonist, with a duration of action which is shorter (3 to 4 hours) than that of heroin. In a clinical trial of naloxone in the treatment of heroin dependence, a daily oral dose of 100 mg. at 8 A.M. and 7 P.M. effectively blockaded 20 mg.
Arnoldo Mora+6 more
openaire +3 more sources
Acute effects of heroin on emotions in heroin‐dependent patients
The American Journal on Addictions, 2013BackgroundEuphoria has been described in heroin‐dependent individuals after heroin administration. However, affective disturbances and disorders are common in heroin dependence. The present study examined the acute effects of heroin on emotions in heroin‐dependent patients.MethodsThis randomized controlled crossover trial included 28 heroin‐dependent ...
Blum, J.+8 more
openaire +4 more sources
Buprenorphine and Naloxone for Heroin Dependence
Current Psychiatry Reports, 2000The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique profile results in greater safety, less physical dependence, and greater flexibility in dose scheduling.
Jeffrey C. McCagh, Rolley E. Johnson
openaire +3 more sources